ePharmage

New research is emerging from the Vanderbilt Eye Institute that indicates the first sign of injury in glaucoma occurs in the brain.

The Congress of the French Ophthalmology Society, SFO, will take place at the Palais des Congres, 2 place de la Porte Maillot, Paris, France, 8-11 May 2010.

A House panel Tuesday night stripped laser surgery by optometrists from the most controversial and divisive bill this winter, setting up an inevitable clash with the Senate in the final four days of the 2010 session.

Some depression and anxiety drugs are associated with an increased risk of cataracts, new research shows.

Inspire Pharmaceuticals Inc. announced it has initiated two phase II clinical trials with azithromycin ophthalmic solution 1% (AzaSite) to pursue a potential indication for the treatment of blepharitis. The drug currently is approved by the FDA for the treatment of bacterial conjunctivitis.

Novagali Pharma announced that the company's investigational new drug application to conduct a phase III clinical trial of Nova21027 (Catioprost), a cationic emulsion of latanoprost for the treatment of glaucoma, has been granted by the FDA.

Novartis plans to assume complete control over Alcon Laboratories Inc. in a two-step process that some analysts and some members of Alcon?s board of directors are challenging for its fairness under Swiss and US merger laws.

The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm.

Interim results from a Phase II study by Gene Signal suggest that antisense oligonucleotide GS-101 is safe and effective at inhibiting abnormal corneal new blood vessel growth.

High levels of the enzyme arginase contributes to vascular eye damage, and therapies to lower its levels could halt progression of diabetic retinopathy (DR), according to researchers at the Medical College of Georgia (MCG) School of Medicine, USA.

The pathology of glaucoma is likely to be related to the presence and levels of selenium, according to the results of a study published in the August issue of the British Journal of Ophthalmology.

A new study conducted by researchers at the University of Aberdeen, Scotland, has found that the brain predicts the consequences of eye movement even before the eyes take in a new scene.

Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising.

The FDA has approved a new drug application (NDA) for ganciclovir ophthalmic gel 0.15% (Zirgan, Sirion Therapeutics) as a treatment for acute herpetic keratitis (dendritic ulcers), the company announced.

Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8.

Presbia Coöperatief U.A. of Amsterdam unveiled an implantable micro-lens treatment (Flexivue System) for presbyopia at the European Society of Cataract and Refractive Surgeons annual meeting.

AMD Alliance International is hosting a video contest to raise awareness for age-related macular degeneration (AMD). Individuals are invited to create and submit videos of no longer than 3 minutes that will communicate in the most creative and visually interesting ways the impact of AMD.

Heidelberg Engineering has two new models in its family of multimodality ophthalmic imaging devices (Spectralis).

Do you often feel embarrass when you see the wrinkles on your eye lids when you sit in front of the mirror before going for a party? What will happen when the men in the party will guess your age? Dr. Nadia Kazim has a solution. Dr. Nadia Kazim, an eyelid and facial cosmetic surgeon at [...]

Do you ever considered this fact that people must have the right to avail all the health facilities available in the country? When it comes to eye care the concern is much bigger. Here is a piece which shows our very popular ex-President Dr. APJ Abdul Kalam fights for the cause. While calling upon all the [...]

WASHINGTON - Optometrists at the University of Alabama at Birmingham (UAB) have come up with a new breed of contact lenses that can treat presbyopia, a gradual loss of the ability to focus on nearby objects. According to Adam Gordon, O.D., M.P.H., an associate professor in the [...]

Allergan eye surgery drug gets FDA approval IRVINE, Calif. — Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail. The eye solution is aimed at treating pain and inflammation following cataract surgery. Allergan said there are more than 3 million cataract surgeries [...]

Allergan eye surgery drug gets FDA approval IRVINE, Calif. — Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail. The eye solution is aimed at treating pain and inflammation following cataract surgery. Allergan said there are more than 3 million cataract surgeries [...]

Glaucoma is the biggest cause of blindness in New Zealand, affecting about 68,000 people. Sadly, one in two victims don't know they are being robbed. Right now about 34,000 people in New  Zealand are going blind but they don't  know it. Glaucoma NZ chairwoman Helen Danesh-Meyer says efforts to detect early signs of the disease must be [...]

Currently, surgeons are employing combination techniques of bone and fat decompression to treat thyroid eye disorders, depending on the clinical situation. Prospective studies are needed to establish the ideal operative approach to minimize postoperative complications with the best cosmetic outcome in mind. Despite the multiple options available, it is most important to tailor the surgical approach to meet the individual needs of the patient.

All patients presenting with open-globe injuries should be treated as aggressively as possible, but a recent study shows that the presence of an afferent pupillary defect is the best indicator of permanent visual loss in these patients.

Ablative skin rejuvenation procedures often are associated with prolonged healing, and can cause scarring, prolonged erythema, and hyperpigmentation.

Management of thyroid eye diseases should be individualized to the severity of signs and symptoms of each patient and based as well on whether the disease is in an active or quiescent phase. Some corrective procedures should be postponed for months or years until the disease no longer is active.

Facial rejuvenation procedures can be worthwhile adjuncts to an ophthalmology practice. Surgeons, however, require detailed knowledge of products and anatomy, must make patient education a priority, and should obtain specific training. Patients undergoing cosmetic procedures often have very high expectations, and it is important to have an in-depth understanding of aesthetic facial anatomy and features.

San Francisco—Treatment of low-to-high myopia with transepithelial PRK (tPRK) has poorer predictability and results in greater induction of corneal spherical aberration compared with epi-LASIK, reported Osamu Hieda, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

Las Vegas—UVA-induced collagen cross-linking (CCL) followed by surface excimer ablation shows promise as a safe and effective technique for visual rehabilitation in eyes with keratoconus or post-LASIK ectasia, said A. John Kanellopoulos, MD, at the annual meeting of the American Academy of Ophthalmology.

Las Vegas—Results of a study comparing customized PRK plus mitomycin-C (MMC) against customized LASIK indicate that both are excellent techniques for treating compound myopic astigmatism but suggest that the surface ablation procedure may be somewhat superior, said Anelise D. Wallau, MD, here at refractive surgery subspecialty day, part of the annual meeting of the American Academy of Ophthalmology.

Seoul, Korea—Intraoperative use of mitomycin-C (MMC) is a safe and effective method for preventing corneal haze in eyes undergoing PRK, said Dongho Lee, MD, PhD, director, Yonsei Eye Center, Seoul, South Korea.

Minneapolis—Wavefront surface ablation seemed to be a safe and effective treatment for patients with substantial degrees of coma or trefoil in the early follow-up period. The 1-year data in a small number of eyes showed that the results remained stable, according to David R. Hardten, MD.

)? Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD). The groundbreaking clinical trial is being conducted at seven European sites, and will include a minimum of 150 patients, with approximately one third of those receiving a sham exposure and the remainder receiving radiation dosing of either 16 or 24 Gray (GY).

Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

The results of a study published in the July issue of Ophthalmology has discovered that people in the early stages of age-related macular degeneration (AMD) are at a higher risk of developing coronary heart disease (CHD), offering further support to the theory that AMD is associated with underlying systemic vascular disease.

Prevalence and incidence of advanced AMD can be catergorized as 'nature' or 'nurture' using a prediction model, based on genetic, environmental and demographic variables.

The twelve-month primary analysis results from the Novartis sponsored Phase II MONT BLANC study investigating the efficacy and safety of combining Visudyne (Novartis Pharma AG) and Lucentis (Novartis Pharma AG, Genentech Inc.) have been released and so far are showing no significant differences.

Las Vegas—When considering the use of intravitreal triamcinolone acetonide (IVTA) in patients with diabetic macular edema (DME), ophthalmologists should be mindful that cataract is a common complication and is particularly challenging in young patients with clear lenses and still-useful accommodation, according to a study reported by Moncef Khairallah, MD, here at the annual meeting of the American Academy of Ophthalmology.

Chest and joint radiographs, CT, MRI, and other extraocular imaging modalities must be tailored to each patient and not ordered routinely.

Ptosis is a sign of a number of diseases, most of which are benign. Julie Falardeau, MD, of the Casey Eye Institute, Portland, OR, described how ophthalmologists can avoid overlooking myasthenia gravis, which can be associated with serious morbidity and mortality.

The electronic database of a large health-maintenance organization was used to identify patients who had a positive temporal artery biopsy indicating a diagnosis of giant cell arteritis (GCA). The calculated incidence of GCA was significantly less than previously reported and is thought to reflect, in part, differences in population demographics between studies.

The Anecortave Acetate Risk Reduction Trial (AART) recently completed enrollment of 2,596 patients worldwide. The study is being conducted in the United States, Europe, Australia, and South America. Sites have also been added in India and Singapore under a different protocol number. AART is investigating the ability of anecortave acetate 15 mg or 30 mg to prevent sight-threatening choroidal neovascularization (CNV) in high-risk eyes when compared with a sham procedure.

About one-third of patients displayed improvement in visual acuity at 1, 2, and 3 months after injection.

Anterior and posterior capsulorhexis in children

The Egyptian Group of Paediatric Eye Surgery (EGPES) will be hosting the 4th International Symposium of Paediatric Ophthalmology, from 4th to 6th of November 2009, in Alexandria, Egypt.

See by Three, a program of the Children's Eye Foundation, has completed the first phase of its national research project to advocate effective screening of children for amblyopia so they will "see by three".

Healthy vision is vital for success in life and should begin with regular vision screenings during childhood, but the level of inadequate vision care for children in the United States is significant, however. The author addresses ways to address this issue to positively affect high school graduation rates, social and emotional problems, juvenile delinquency, adult literacy problems, incarcerations, and workforce quality and productivity.

The use of implantable collamer lenses (ICLs) to correct moderate to high myopia can offer predictable and stable results over a long period of time, according to a report published in the July issue of Archives of Ophthalmology.

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Volk Optical, the industry leader in aspheric optics, will be exhibiting at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, April 9 through 14 at the Boston Convention & Exhibition Center (Massachusetts).

STAAR Surgical Company a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, including the Visian Implantable Collamer Lens (ICL), today congratulated Steve Holcomb for leading the United States Bobsled team on Saturday evening to its first gold medal win in 62 years. In 2008, Holcomb, who was extremely nearsighted and suffered from the degenerative eye condition keratoconus, had a STAAR Visian ICL implanted in each eye to correct the nearsightedness. Immediately, his vision improved from a reported 20/500 to 20/20, and he was able to resume his quest for Olympic gold.

We're sorry -- no content is currently available for Written by Physicians, For Physicians Ophthalmology Times is an award-winning physician-driven publication that disseminates news and information of a clinical, socio-economic, and political nature in a timely and accurate manner for members of the ophthalmic community.

San Francisco—Refractive-cataract surgeons now have a tool to guide the outcomes of their cataract procedures (ORange Intraoperative Wavefront Aberrometer, WaveTec Vision).

The FDA has granted premarket approval to a new pachymeter/auto-refractor/keratometer (PARK 1, Oculus).

Postoperative anterior optical coherence tomography may provide a more accurate measurement of LASIK flap thickness than intraoperative subtraction pachymetry.

The multi-component IOL (PrecisionLens) is a novel, foldable implant technology consisting of three optical elements (two exchangeable) that was created to produce an emmetropic result reliably in all patients who undergo cataract surgery or refractive lens exchange.

Arriving at the proper IOL power is difficult to achieve in patients who have undergone prior cornea-altering refractive procedures such as LASIK, PRK, or RK.

Palo Alto, CA—Darius Moshfeghi, MD, pediatric retina specialist at Lucile Packard Children's Hospital, Palo Alto, CA, and one of just a few physicians in California's Bay Area trained to diagnose retinopathy of prematurity (ROP), is using technology to bring his expertise to premature babies without having to travel to see them.

Calgary, Alberta—Serial digital fundus imaging with remote interpretation by experienced physician graders is accurate for detecting clinically significant retinopathy of prematurity (CSROP), according to the results of the Photographic Screening Trial for Retinopathy of Prematurity (PhotoROP).

Retinitis pigmentosa and AMD may be the beneficiaries of a new tool for gene therapy that significantly increases gene delivery to cells in the retina.

The NAVILAS laser system, as reported on in the OTE Digest back in May this year ( What is Retinal Navigation? ) has been given FDA approval.

The FDA has granted 510(k) clearance to a new digital fundus camera (TRC-NW7SF Mark II, Topcon Medical Systems), according to its manufacturer.

Diabetic macular edema responds to treatment with ranibizumab (Lucentis, Genentech), according to results of the RESOLVE study. The patient responses to the drug in the changes in the visual acuity and central macular thickness were significantly better in the groups treated with two concentrations of ranibizumab compared with the sham-treated group.

As you read this, you may notice that the word directly in front of you is clear, but all the surrounding words are hard to make out. For most people, this effect - known as 'crowding' - is not a problem. However, for the millions of people worldwide who have lost their central vision through eye disease such as macular degeneration, it can make everyday tasks such as reading or recognising friends a challenge.

Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.

Northeastern University engineering professor Jeffrey Ruberti and his research colleagues are breaking new ground in the technique known as "hybrid tissue engineering" by attempting to combine cow tissue with human tissue to produce corneas for human transplant.

Researchers are looking into corneal biomechanics as a means to screen patients for keratectasia. The authors review signal interpretation from a non-contact applanation tonometer as it relates to corneal biomechanical indices such as corneal hysteresis.

A comparison of an older nanoliter osometer and a newer osometer shows that both devices are effective in measuring tear osmolarity and produce comparable measurements.

A recent study showed that moderate to sever dr eye disease can be best treated with anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can significantly limit progression of dry eye disease and should be considered a 'go-to' therapy for this patient population.

A new technique of intraductal meibomian gland probing using disposable cannulas of various lengths appears highly effective in providing quick and lasting relief from inflammatory sysmptoms of obstructive meibomian gland disease.

The use of hydroxypropyl cellulose can significantly improve the symptoms of dry eye, resulting in increased quality of life.

An oil-in-water and a corticosteroid were both effective in eliminating the signs and symptoms of lid wiper epitheliopathy after a 1-month active treatment phase in a recent study. Improvement was effectively maintained with the emollient eye drops in all patients over a 12-month period.

Glaucoma remains the world's leading cause of irreversible blindness, but 50% of people who have this devastating disease don't know it,” said Dr Clive Midgal, president of the European Glaucoma Society.

The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon.

SYDNEY - A powerful new technique, developed by scientists, can quantify damage caused by serious eye diseases affecting tens of millions worldwide. Known as multifocal pupillography, the method involves monitoring minute responses of the eye's pupil to light signals in different parts of the patient's visual field. ARC Vision Centre and Australian National University [...]

WASHINGTON - Glaucoma patients and dry-eye sufferers may soon be able to trade their messy eye drops for a contact lens that delivers medication gradually over time, say scientists. Medication through eye drops tends to be highly ineffective, not because the drugs are impotent, but because of the body's own natural defences. Blinking and watery eyes are [...]

Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8.

Aton Pharma has launched new education, distribution, sampling, and reimbursement programs for its preservative-free formulation of timolol maleate (Timoptic in Ocudose), which according to the company is the only preservative-free medication for glaucoma available in the United States.

Volk Optical, the industry leader in aspheric optics, will be exhibiting at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, April 9 through 14 at the Boston Convention & Exhibition Center (Massachusetts).

NAPLES, Fla. - Annual estimates of the number of trabeculectomy cases performed in the U.S. are declining, while other forms of glaucoma surgical treatment have been increasing in use, according to Medicare data.

A laser-based surgical device has been shown during trials to provide a safe, non-penetrating method of reducing intraocular pressure (IOP), according to study results published by the developer of the device, IOPtima Ltd.

Various imaging devices fail to identify localized retinal nerve fibre layer (RNFL) defects, according to a study published in the January issue of the British Journal of Ophthalmology.

The TrueField Analyser, a glaucoma testing device, has been hailed by reseachers at the Australian National University as offering faster, more comprehensive and more accurate diagnoses than current methods.

New imaging techniques are allowing more objective quantification of glaucoma diagnosis and progression, according to study results published online ahead of print by the British Journal of Ophthalmology.

The lack of experience with evidence-based guidelines may be the reason for excessive follow-up after screening for hydroxychloroquine retinopathy, according to study results published in the December issue of the British Journal of Ophthalmology.

Diagnosing and managing dry eye patients can be challenging. Here Dr Philipp Steven looks at a new way of treating tear film osmolarity, the TearLab Osmolarity System, which he believes could dramatically simplify the process.

Foresight Biotherapeutics, Inc. has announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis.

BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.

According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.

The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.

In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).

Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy.

San Francisco—In a study that quantified the anterior movement of an accommodative IOL (HumanOptics 1CU lens), the investigators reported an anterior shift of less than 0.5 D of accommodation, which was disappointing in that patients were not spectacle-independent, according to Eduardo Marques, MD, who spoke here at the American Society of Cataract and Refractive Surgery annual meeting.

San Francisco—In an initial analysis, the Synchrony dual-optic single-piece IOL (Visiogen) performed well. The visual results were good, there were no major complications and no glare or halos after implantation, and patient satisfaction was high, according to George Beiko, BM, BCh, FRCS.

Cape Coral, FL—New-generation refractive IOLs that provide a range of vision are valuable additions for a standard cataract practice, said Farrell C. Tyson II, MD.

Fewer than 10 years ago I sat in the audience at the first "Array Familiarization Course" offered in San Francisco at the conclusion of the American Academy of Ophthalmology annual meeting. A highlight of the course for me was I. Howard Fine, MD's response to a question about the best refractive procedure for a 60-year-old patient with 6 D of myopia. The first FDA approvals for excimer laser ablation recently had come through, and LASIK was on everyone's mind. Dr. Fine, however, proposed refractive lens exchange with the Array lens, offering complete spectacle independence. The idea clicked.

Lasik eye surgery has become a viable alternative to contact lenses and glasses for young adults. It gives them a chance to experience near-perfect vision without the hassle of contact lenses and glasses. Dr. Charles Cowan, an optometrist at Auburn Eye Care, described the ideal candidate for Lasik eye surgery. “Broadly speaking, the procedure has been done [...]

Eminent senior ophthalmologist at King's college London, professor John Marshall, who was famous for leading the way to find the laser eye surgery procedure to cure short sightedness, yet again successfully established a new laser technique which could prevent blindness effectively. Professor John Marshall's new laser technique can delay the onset of age-related macular degeneration (AMD), [...]

World eye center claimed that its 13th branch, at Ankara, Turkey is the largest private eye hospital of the world. Itcost at least 30 million dollar to built up the 15, 000 square meter, 18-story smart building. The Titanic hospital will offers the latest in eye care technology and equipment. With its unique architecture, quality service, [...]

With the advent of intrastromal ablation technique lasik eye surgery finds a new dimension. It has added something like an insurance policy against the risks involved in any type of surgery. But with the development of femtosecond techniques and intrastromal ablation things are potent to be revolutionized. Moreover it will provide the patients to gofor [...]

The debate among LASIK surgeons concerning the best way to create a corneal flap during the laser eye surgery continues. In the March 1, 2009 edition of Ocular Surgery News (Europe/Asia-Pacific Edition), two experienced LASIK surgeons offer their views about which flap creation technique is superior. Though most LASIK surgeons use a precise cutting tool called a [...]

A comparative evaluation of local anaesthesia for cataract surgery, published in The Journal of Cataract & Refractive Surgery says that randomized clinical trials are needed to facilitate statistical methods of metaanalysis to establish convincingly the overall benefits and efficacy of the various local anesthesia procedures in cataract surgery.

Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators.

Cataract surgery gets a new type of surgery in the form of DisCoVisc. It is promising to be complication free as compared to existing surgeries. But is it better than Healon Surgery? The DisCoVisc ophthalmic surgery device can be used as an alternative to the Healonviscoelastic device in cataract surgery, according to a study presented here [...]

More than 3 million Americans are affected from cataract and undergoes surgery to get only a below average vision. Here is a new technology that promises to gift you a perfect clarity, after you undergo a cataract operation. As a former actor, Max Segar has had a lifelong love of the movies. Recently though, he has [...]

WASHINGTON - Optometrists at the University of Alabama at Birmingham (UAB) have come up with a new breed of contact lenses that can treat presbyopia, a gradual loss of the ability to focus on nearby objects. According to Adam Gordon, O.D., M.P.H., an associate professor in the [...]

WASHINGTON - Glaucoma patients and dry-eye sufferers may soon be able to trade their messy eye drops for a contact lens that delivers medication gradually over time, say scientists. Medication through eye drops tends to be highly ineffective, not because the drugs are impotent, but because of the body's own natural defences. Blinking and watery eyes are [...]

There is a rising concern among the ophthalmologists lately is that about eye injury. If you are a sportsperson we are sure that you must know that you are in the danger zone. Apart from the sports personalities we, who go out in the sun for our day to day work, are exposed to a lot [...]

Lasik eye surgery has become a viable alternative to contact lenses and glasses for young adults. It gives them a chance to experience near-perfect vision without the hassle of contact lenses and glasses. Dr. Charles Cowan, an optometrist at Auburn Eye Care, described the ideal candidate for Lasik eye surgery. “Broadly speaking, the procedure has been done [...]

Its a story of a boy who saw himself treating people's eye in future. The boy is now none other than Dr. John Eigenbrodt, a name in eye care. At 10 years old, Dr. John Eigenbrodt was given a model eye by his uncle. "It sparked an interest for me," says Eigenbrodt. "I had always wanted to [...]

WASHINGTON - Optometrists at the University of Alabama at Birmingham (UAB) have come up with a new breed of contact lenses that can treat presbyopia, a gradual loss of the ability to focus on nearby objects. According to Adam Gordon, O.D., M.P.H., an associate professor in the [...]

Do you often get in a fix when someone asks about your dark circles , or when someone guesses your age from your wrinkles over your eyes? Well, to cut a long story short read through. The story often goes like this: You run into a friend you haven't seen in ages, and, after the initial [...]

Glaucoma is the biggest cause of blindness in New Zealand, affecting about 68,000 people. Sadly, one in two victims don't know they are being robbed. Right now about 34,000 people in New  Zealand are going blind but they don't  know it. Glaucoma NZ chairwoman Helen Danesh-Meyer says efforts to detect early signs of the disease must be [...]

Did you know that Vitamin D protects your eyes from eye conditions like macular degeneration and blindness? Vitamin D has been well known for preventing bone deformities, but recently it has been revealed to be effective in eye care too. Two years ago a study appeared in the Archives of Ophthalmology that showed that people who [...]

Do you often feel embarrass when you see the wrinkles on your eye lids when you sit in front of the mirror before going for a party? What will happen when the men in the party will guess your age? Dr. Nadia Kazim has a solution. Dr. Nadia Kazim, an eyelid and facial cosmetic surgeon at [...]

WASHINGTON - Optometrists at the University of Alabama at Birmingham (UAB) have come up with a new breed of contact lenses that can treat presbyopia, a gradual loss of the ability to focus on nearby objects. According to Adam Gordon, O.D., M.P.H., an associate professor in the [...]

WASHINGTON - Glaucoma patients and dry-eye sufferers may soon be able to trade their messy eye drops for a contact lens that delivers medication gradually over time, say scientists. Medication through eye drops tends to be highly ineffective, not because the drugs are impotent, but because of the body's own natural defences. Blinking and watery eyes are [...]

Do you often get in a fix when someone asks about your dark circles , or when someone guesses your age from your wrinkles over your eyes? Well, to cut a long story short read through. The story often goes like this: You run into a friend you haven't seen in ages, and, after the initial [...]

There is a rising concern among the ophthalmologists lately is that about eye injury. If you are a sportsperson we are sure that you must know that you are in the danger zone. Apart from the sports personalities we, who go out in the sun for our day to day work, are exposed to a lot [...]

Lasik eye surgery has become a viable alternative to contact lenses and glasses for young adults. It gives them a chance to experience near-perfect vision without the hassle of contact lenses and glasses. Dr. Charles Cowan, an optometrist at Auburn Eye Care, described the ideal candidate for Lasik eye surgery. “Broadly speaking, the procedure has been done [...]

Allergan eye surgery drug gets FDA approval IRVINE, Calif. — Allergan Inc., which makes eye-care products and Botox, said Thursday it received Food and Drug Administration approval for its post-cataract surgery eye solution Acuvail. The eye solution is aimed at treating pain and inflammation following cataract surgery. Allergan said there are more than 3 million cataract surgeries [...]

LONDON - Evidence from tissue culture experiments show that popular dietary supplement carnosine may help prevent and treat cataracts, which is a leading cause of vision loss worldwide. Enrico Rizzarelli from the University of Catania (Italy) who led the study and colleagues note that the only effective treatment for cataracts is surgical replacement of the lens, [...]

Volk Optical, the industry leader in aspheric optics, will be exhibiting at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, April 9 through 14 at the Boston Convention & Exhibition Center (Massachusetts).

Postmenopausal women undergoing long-term hormone replacement therapy may have an elevated risk of cataract, according to a large Swedish study.